Panretin Gel
Company: Ligand PharmaceuticalsApproval Status: Approved June 1999
Treatment for: Infectious Diseases
Areas: Immune System
General Information
Panretin (alitretinoin) Gel, 0.1%, has been approved for the treatment of cutaneous lesions in patients with AIDS-related Kaposi's sarcoma.
Panretin Gel Drug Information
The Panretin Gel drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
